找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: G Protein-Coupled Receptors in Drug Discovery; Wayne R. Leifert Book 2009 Humana Press 2009 Calcium.Cellular signalling.Chemokine.Drug dev

[復(fù)制鏈接]
樓主: Inoculare
31#
發(fā)表于 2025-3-26 23:20:21 | 只看該作者
32#
發(fā)表于 2025-3-27 02:56:08 | 只看該作者
33#
發(fā)表于 2025-3-27 08:27:06 | 只看該作者
New Insights into GPCR Function: Implications for HTS,ique targeted therapeutic uses, including “designer” drugs such as allosteric regulators, inverse agonists, and drugs targeting hetero-oligomeric complexes. This has been facilitated by the development of new screening technologies to identify novel drugs against both known and orphan GPCRs.
34#
發(fā)表于 2025-3-27 09:26:48 | 只看該作者
An Overview on GPCRs and Drug Discovery: Structure-Based Drug Design and Structural Biology on GPCRf structure-based drug design has been possible. Much effort has been dedicated to structural biology on GPCRs and very recently an X-ray structure of the β2-adrenergic receptor was obtained. This breakthrough will certainly increase the efforts in structural biology on GPCRs and furthermore speed up and facilitate the drug discovery process.
35#
發(fā)表于 2025-3-27 16:02:02 | 只看該作者
36#
發(fā)表于 2025-3-27 20:33:57 | 只看該作者
37#
發(fā)表于 2025-3-27 23:53:10 | 只看該作者
BacMam: Versatile Gene Delivery Technology for GPCR Assays,ample, coexpression of a receptor and a G protein or a reporter gene. BacMam viruses are compatible with the GPCR cell-based assay formats typically used in high-throughput screening and provide an unparalleled level of experimental flexibility that is simply not possible when using stable recombinant cell lines.
38#
發(fā)表于 2025-3-28 03:58:22 | 只看該作者
39#
發(fā)表于 2025-3-28 08:17:58 | 只看該作者
Resonant Waveguide Grating Biosensor for Whole-Cell GPCR Assays,disease relevant environments. We have shown that these biosensor assays enable high-throughput screening of pathway-biased ligands acting on endogenous β.-adrenergic receptor in cells. These biosensor cellular assays hold the potential to reduce attrition rates in drug discovery and development process.
40#
發(fā)表于 2025-3-28 11:17:26 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 03:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
堆龙德庆县| 大邑县| 临沧市| 项城市| 新营市| 汝阳县| 布拖县| 祥云县| 石屏县| 达日县| 天等县| 佛坪县| 错那县| 永嘉县| 夹江县| 彭泽县| 夏河县| 纳雍县| 浦江县| 梨树县| 满城县| 鹤山市| 拉孜县| 麻阳| 西峡县| 安塞县| 太原市| 鹤壁市| 上犹县| 安乡县| 三台县| 璧山县| 革吉县| 柞水县| 墨脱县| 襄樊市| 顺昌县| 长乐市| 方正县| 寿阳县| 麻江县|